⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1982189 | 0.69 | — | — | |
| SCHEMBL12123460 | 0.69 | ALDH1A1 (0.35) | — | |
| SCHEMBL7883058 | 0.69 | ALDH1A1 (0.35) | — | |
| SCHEMBL5087892 | 0.69 | ALDH1A1 (0.35) | — | |
| Water SCHEMBL8986201 | 0.69 | LOX (0.30) | — | |
| SCHEMBL181823 | 0.67 | — | — | |
| SCHEMBL11045713 | 0.67 | — | — | |
| Methyl Alcohol SCHEMBL7435412 | 0.67 | — | — | |
| Methane SCHEMBL10705120 | 0.66 | MEN1 (0.31) | — | |
| SCHEMBL1164528 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11858907-B2 | Kinase modulators | RHIZEN PHARMACEUTICALS AG (CH) | 2024-01-02 | — | — | US | disclosed |
| EP-3098230-B1 | THIOETHER COMPOUND FOR THE PROTECTION OF THE 2'-HYDROXY GROUP IN NUCLEOSIDES TO BE USED IN OLIGONUCLEOTIDE SYNTHESIS. | BONAC CORP (JP) | 2020-05-06 | — | — | EP | disclosed |
| CN-107102082-B | Method for determining residual quantity of amitraz and metabolite thereof in royal jelly by liquid chromatography-mass spectrometry/mass spectrometry | 浙江省检验检疫科学技术研究院 | 2019-12-17 | — | — | CN | disclosed |
| US-10442783-B2 | 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases | RHIZEN PHARMACEUTICALS SA (CH) | 2019-10-15 | — | — | US | disclosed |
| US-9988415-B2 | Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid | BONAC CORPORATION (JP) | 2018-06-05 | — | — | US | disclosed |
| EP-2749565-B1 | NUCLEOSIDE PHOSPHORAMIDATES FOR PRODUCING NUCLEIC ACIDS | BONAC CORP (JP) | 2017-05-31 | — | — | EP | disclosed |
| EP-3098230-A1 | THIOETHER COMPOUND FOR THE PROTECTION OF THE 2'-HYDROXY GROUP IN NUCLEOSIDES TO BE USED IN OLIGONUCLEOTIDE SYNTHESIS. | Bonac Corporation (JP) | 2016-11-30 | — | — | EP | disclosed |
| US-9481702-B2 | Glycoside compound, method for producing thioether, ether, method for producing ether, method for producing glycoside compound, method for producing nucleic acid | BONAC CORPORATION (JP) | 2016-11-01 | — | — | US | disclosed |
| US-9421209-B2 | Kinase modulators | RHIZEN PHARMACEUTICALS SA (CH) | 2016-08-23 | — | — | US | disclosed |
| US-20160176810-A1 | GLYCOSIDE COMPOUND, METHOD FOR PRODUCING THIOETHER, ETHER, METHOD FOR PRODUCING ETHER, METHOD FOR PRODUCING GLYCOSIDE COMPOUND, METHOD FOR PRODUCING NUCLEIC ACID | BONAC CORPORATION (JP) | 2016-06-23 | — | — | US | disclosed |
| WO-1994008984-A1 | NOVEL TAXANE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | RHONE-POULENC RORER S.A. (FR) | 1994-04-28 | — | — | WO | disclosed |
| US-4652563-A | PYRIDAZINONES SUBSTITUTED WITH CYCLOPROPYLMETHOXYETHYL GROUP | SMITH KLINE & FRENCH LABORATORIES LTD. (GB) | 1987-03-24 | — | — | US | disclosed |
| US-4324905-A | PROSTAGLANDIN F2A, DRUGS | THE UPJOHN COMPANY (US) | 1982-04-13 | — | — | US | disclosed |
| US-4172206-A | CRYSTALLINE PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1979-10-23 | — | — | US | disclosed |
| US-4017535-A | OXYTOCICS, ABORTION, HYPOTENSIVE, ANTISECRETORY | THE UPJOHN COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-4011249-A | Substituted keto and alkoxy carbonyl esters of 16-substituted PGE2 type compounds | THE UPJOHN COMPANY (US) | 1977-03-08 | — | — | US | disclosed |
| US-4010172-A | PROSTAGLANDIN | THE UPJOHN COMPANY (US) | 1977-03-01 | — | — | US | disclosed |
| US-3998869-A | PROSTAGLANDIN E2; HYPOTENSIVE AGENTS, OXYTOCICS, PROPHYLAXIS, ANTISECRETORY AGENTS | THE UPJOHN COMPANY (US) | 1976-12-21 | — | — | US | disclosed |
| US-3994956-A | OXYTOCICS, ANTISECRETORY, HYPOTENSIVE, PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-11-30 | — | — | US | disclosed |
| US-3994957-A | OXYTOCICS, ANTISECRETORY, HYPOTENSIVE, INTERMEDIATES, PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-11-30 | — | — | US | disclosed |